ROYAL BANK OF CANADA - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 29 filers reported holding CASI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$01810.0%0.00%
Q4 2021$01810.0%0.00%
Q3 2021$0
-100.0%
181
-96.0%
0.00%
Q2 2021$7,000
-50.0%
4,494
-27.3%
0.00%
Q1 2021$14,000
-6.7%
6,184
+19.8%
0.00%
Q4 2020$15,0005,164
+3342.7%
0.00%
Q3 2020$0
-100.0%
150
-99.1%
0.00%
Q2 2020$44,000
-42.9%
17,615
-53.5%
0.00%
Q1 2020$77,000
+20.3%
37,889
+82.0%
0.00%
Q4 2019$64,000
+8.5%
20,814
+18.0%
0.00%
Q3 2019$59,000
+5.4%
17,635
+0.5%
0.00%
Q2 2019$56,000
+12.0%
17,545
-0.5%
0.00%
Q1 2019$50,000
-31.5%
17,635
-2.4%
0.00%
Q4 2018$73,000
-18.0%
18,069
-5.3%
0.00%
Q3 2018$89,000
-38.2%
19,088
+8.7%
0.00%
Q2 2018$144,000
+94.6%
17,559
+0.1%
0.00%
Q1 2018$74,000
+27.6%
17,545
-0.6%
0.00%
Q4 2017$58,000
+87.1%
17,649
+0.4%
0.00%
Q3 2017$31,000
+72.2%
17,572
+0.2%
0.00%
Q2 2017$18,000
-28.0%
17,545
-0.2%
0.00%
Q1 2017$25,000
+13.6%
17,572
-10.3%
0.00%
Q4 2016$22,000
+4.8%
19,589
+0.1%
0.00%
Q3 2016$21,000
-4.5%
19,571
+0.1%
0.00%
Q2 2016$22,000
+22.2%
19,544
+11.4%
0.00%
Q1 2016$18,000
+5.9%
17,545
+0.1%
0.00%
Q4 2015$17,00017,536
+11993.8%
0.00%
Q3 2015$01450.0%0.00%
Q2 2015$01450.0%0.00%
Q1 2015$01450.0%0.00%
Q4 2014$01450.0%0.00%
Q3 2014$01450.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 951,064$7,827,0004.06%
Wellington Shields Capital Management, LLC 855,056$7,037,0001.16%
Manatuck Hill Partners, LLC 15,090$124,0000.05%
Moors & Cabot, Inc. 22,935$187,0000.02%
Perceptive Advisors 43,682$360,0000.01%
ROYCE & ASSOCIATES LP 120,000$988,0000.01%
ALPS ADVISORS INC 125,015$1,029,0000.01%
MetLife Investment Management, LLC 26,316$217,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 136,518$1,124,0000.00%
Private Advisor Group, LLC 15,001$122,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders